The Alternative Reading Frame Tumor Suppressor Antagonizes Hypoxia-Induced Cancer Cell Migration via Interaction with the COOH-Terminal Binding Protein Corepressor
Open Access
- 1 October 2007
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 67 (19) , 9322-9329
- https://doi.org/10.1158/0008-5472.can-07-1743
Abstract
The alternative reading frame (ARF) tumor suppressor exerts both p53-dependent and p53-independent activities critical to the prevention of cancer in mice and humans. Recent evidence from mouse models suggests that when p53 is absent, further loss of ARF can widen the tumor spectrum, and potentiate invasion and metastasis. A major target of the p53-independent activity of ARF is the COOH-terminal binding protein (CtBP) family of metabolically regulated transcriptional corepressors, which are degraded upon acute exposure to the ARF protein. CtBPs are activated under conditions of metabolic stress, such as hypoxia, to repress epithelial and proapoptotic genes, and can mediate hypoxia-induced migration of cancer cells. The possibility that ARF could suppress tumor cell migration as part of its p53-independent activities was thus explored. Small-interfering RNA (siRNA)–mediated knockdown of ARF in human lung carcinoma cells led to increased cell migration, especially during hypoxia, and this effect was blocked by concomitant treatment with CtBP2 siRNA. Introduction of ARF into p53 and ARF-null human colon cancer cells inhibited hypoxia-induced migration. Furthermore, overexpression of CtBP2 in ARF-expressing cells enhanced cell migration, and an ARF mutant defective in CtBP-family binding was impaired in its ability to inhibit cell migration induced by CtBP2. ARF depletion or CtBP2 overexpression was associated with decreased PTEN expression and activation of the phosphatidylinositol 3-kinase pathway, and a phosphatidylinositol 3-kinase inhibitor blocked CtBP2-mediated cell migration. Thus, ARF can suppress cell migration by antagonizing CtBP2 and the phosphatidylinositol 3-kinase pathway, and these data may explain the increased aggressiveness of ARF-null tumors in mouse models. [Cancer Res 2007;67(19):9322–9]Keywords
This publication has 30 references indexed in Scilit:
- Loss of Arf causes tumor progression of PDGFB-induced oligodendrogliomaOncogene, 2007
- Redox sensor CtBP mediates hypoxia-induced tumor cell migrationProceedings of the National Academy of Sciences, 2006
- C-terminal binding proteins: Emerging roles in cell survival and tumorigenesisApoptosis, 2006
- Targeting of C-Terminal Binding Protein (CtBP) by ARF Results in p53-Independent ApoptosisMolecular and Cellular Biology, 2006
- p19 Arf Suppresses Growth, Progression, and Metastasis of Hras-Driven Carcinomas through p53-Dependent and -Independent PathwaysPLoS Biology, 2004
- The differential impact of p16INK4a or p19ARF deficiency on cell growth and tumorigenesisOncogene, 2004
- Cytoskeletal mechanisms responsible for invasive migration of neoplastic cellsThe International Journal of Developmental Biology, 2004
- Cues for migrationNature, 2003
- Transcription Corepressor CtBP Is an NAD+-Regulated DehydrogenaseMolecular Cell, 2002
- Requirement for p53 and p21 to Sustain G 2 Arrest After DNA DamageScience, 1998